The UNODC document “Recommended Methods for the Identification and Analysis of Cannabis and Cannabis Products” (ST/NAR/40/REV.1, 2022) provides a comprehensive framework for distinguishing drug‑type cannabis from industrial hemp, notably by using the ratio of tetrahydrocannabinol plus cannabinol to cannabidiol, where a value above one indicates drug‑type material.
In the European context, the manual notes that most cannabis resin seized in Europe now contains 20‑28% delta‑9 THC, roughly double the potency of herbal cannabis, and that industrial hemp varieties must remain below a 0.2% THC limit according to European Union regulations.
The chemistry section details the biosynthesis of phytocannabinoids from cannabigerolic acid via specific synthases, the decarboxylation of tetrahydrocannabinolic acid to THC, and the oxidative degradation of THC to cannabinol, which can be used to estimate sample age. A significant emerging issue is the isomerisation of CBD to delta‑8 THC and delta‑9 THC under acidic conditions, as well as the acid‑catalysed conversion of delta‑9 THC to delta‑8 THC, leading to elevated levels of delta‑8 THC in products such as vape liquids and edibles, which requires high‑resolution gas chromatography‑mass spectrometry or liquid chromatography‑tandem mass spectrometry for positive identification and differentiation of isomers. The manual emphasises that any analytical method used for seized cannabis, including those for neo‑cannabinoids and THC isomers, must be validated and that laboratories should avoid acidic derivatising agents that could artificially induce isomerisation.




